| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/30/2004 | CN1509178A Pharmaceutical composition comprising lysophosphatidic acid |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509169A Use of enantiomeric pure escitalopram |
| 06/30/2004 | CN1509168A Novel treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1508265A Interleukin-2 and tes method of its gene in drug-stopping application |
| 06/30/2004 | CN1507918A Transdermal promotor glycerin triacetate |
| 06/30/2004 | CN1507912A Medicine for treating hemicrania and therapeutic method thereof |
| 06/30/2004 | CN1507900A Face-nourishing brain-tonifying and spirit-reinforcing liquid |
| 06/30/2004 | CN1507883A Alcoholism relieving pill |
| 06/30/2004 | CN1507872A Use of P-phenylaldehyde-O-beta-D-allopyranoside for treating depression |
| 06/30/2004 | CN1507867A Use of alkaloid compounds in preparing medicine |
| 06/30/2004 | CN1507866A Bulley aconitne transdermal paster |
| 06/30/2004 | CN1155706C Method for treating amyotrophic lateral sclerosis |
| 06/30/2004 | CN1155602C Thineopyranecarboxyamide derivatives |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155596C New phenylpiperazines |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155592C Process for preparing total jujuboflavone with calmative and hypnosis action |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155574C Ether muscarinic antagonists |
| 06/30/2004 | CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 06/30/2004 | CN1155567C Antipsychotic indolyl derivatives |
| 06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 06/30/2004 | CN1155410C Composition for treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 06/30/2004 | CN1155379C Use of Yiliqutan in preparing medicine for preventing recurrence of cephalagra |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756511 Treating alzheimer's disease by preventing formation of insoluble amyloid beta and arresting its production |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756409 For therapy and prophylaxis of pain and/or neurodegenerative disorders |
| 06/29/2004 | US6756400 Diaromatic compound containing 2-amine groups, useful for treating neuropathic pain |
| 06/29/2004 | US6756398 Positive modulators of nicotinic receptor agonists |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756394 Small molecule inhibitors of necrosis |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756389 Pharmaceutically active compounds and methods of use |
| 06/29/2004 | US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 06/29/2004 | US6756386 Such as 1-methyl-3-oxy-(5-chloro-3-pyridyl)-piperidine; cholinergic system of central nervous system; pain, inflammation |
| 06/29/2004 | US6756385 Imidazole derivatives |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
| 06/29/2004 | US6756375 Estrogen receptor modulation; hormone replacement therapy |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756370 Piperidine alcohols |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756357 Variants of human ciliary neurotrophic factor (hCNTF) |
| 06/29/2004 | US6756053 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2204451C Method of selecting a salt for making an inclusion complex |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/29/2004 | CA2038669C Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| 06/24/2004 | WO2004052894A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
| 06/24/2004 | WO2004052889A1 Compounds as radioligands for the diagnosis of disease |
| 06/24/2004 | WO2004052880A1 Pyridine derivatives as jnk inhibitors and their use |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 06/24/2004 | WO2004052858A2 Inhibitors of monoamine uptake |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052841A1 Carbidopa prodrugs and uses thereof |
| 06/24/2004 | WO2004052461A1 Combination for the treatment of adhd |
| 06/24/2004 | WO2004052389A2 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/24/2004 | WO2004052383A1 An composition containing triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 06/24/2004 | WO2004052377A1 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia |
| 06/24/2004 | WO2004052354A1 Propofol-containing fat emulsions |
| 06/24/2004 | WO2004052350A2 Method of treating movement disorders using barbituric acid derivatives |
| 06/24/2004 | WO2004052348A2 Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds |
| 06/24/2004 | WO2004052342A1 A new oral immediated release dosage form |
| 06/24/2004 | WO2004043982A3 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004018044A8 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2004008101A3 The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 06/24/2004 | WO2003105724A3 Novel maxi-k channel blockers, methods of use and process for making the same |
| 06/24/2004 | WO2003103583A3 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | WO2003014309A3 Interleukin-1 receptors in the treatment of diseases |
| 06/24/2004 | WO2002038141A3 Compositions and methods for treatment of mild cognitive impairment |
| 06/24/2004 | WO2002036072A3 Method for short-term and long-term drug dosimetry |
| 06/24/2004 | US20040122254 Selective cyclooxygenase-2(COX-2) inhibitors; free of gastrointestinal side effects; treating eye disorders such as glaucoma or selective cyclooxygenase-2(COX-2) inhibitors, rheumatoid arthritis, arthritis, pain, inflammation |
| 06/24/2004 | US20040122230 Opiate analogs selective for the delta -opioid receptor |
| 06/24/2004 | US20040122100 which contain EP1 agonist (which activate EP1 receptor that is subtype of prostaglandin E2 receptor) as an active ingredient |
| 06/24/2004 | US20040122092 Hydroxyphenylundecane, a process for their production and their use |
| 06/24/2004 | US20040122082 A drug, a food, a beverage or a feed, each having an effective ingredient of a coumarin and/or a chroman compound having an enhancing action for nerve growth factors (NGF) production; nervous system disorders; Alzheimer's disease; plant extracts |
| 06/24/2004 | US20040122076 The use of 1-(iso)indolylsulfonamido-),4-(alkylamido-)benzenes and derivatives as 5-Ht6receptor antagonists; Alzheimer's disease; neurodegenerative diseases; prophylaxis |
| 06/24/2004 | US20040122051 Methods for treating cognitive impairments or dementia |
| 06/24/2004 | US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis |
| 06/24/2004 | US20040122047 Substituted tetrahydroisoquinolines |
| 06/24/2004 | US20040122044 Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations |
| 06/24/2004 | US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof |